Nuvace is a tablet from Orion Pharma Ltd., with the generic name Ramipril. Nuvace is prescribed for three main situations: high blood pressure, where it may be used alone or with other antihypertensive medicines; congestive heart failure, sometimes together with diuretics; and for patients who, in the first days after an acute heart attack, show clinical signs of congestive heart failure.
There are 42 brands of Ramipril listed in Bangladesh. 29 of them have a lower unit price than Nuvace. The lowest listed price is Ramoril 1.25 mg Tablet at ৳ 2.5 per unit.
What is Nuvace 5 mg Tablet?
Nuvace 5 mg is a tablet product of Orion Pharma Ltd. that contains Ramipril. Your doctor sets the strength and how often you take it. Ramipril is long acting and can be used for long-term therapy. Always follow your doctor's advice.
Uses of Nuvace
Nuvace is prescribed for three main situations: high blood pressure, where it may be used alone or with other antihypertensive medicines; congestive heart failure, sometimes together with diuretics; and for patients who, in the first days after an acute heart attack, show clinical signs of congestive heart failure. It is not a medicine for sudden illness and should be taken only under a doctor's care. Your doctor will confirm whether it suits your condition.
How to use Nuvace
Regular follow-up is important to monitor your progress. Swallow the tablet with water. Nuvace is taken by mouth. Do not attempt to use it yourself. Do not stop taking it without asking your doctor, even if you feel well, because blood pressure often has no symptoms. The doctor decides the dose and how long you take it, and may adjust it over time based on how you respond and tolerate it.
Side effects of Nuvace
Less common side effects are low blood pressure with symptoms like lightheadedness, cough, nausea, vomiting, diarrhoea, rash, and hives. Nuvace 5 mg is generally well tolerated, but some people notice dizziness, headache, tiredness or weakness. Commonly reported ones include dizziness, headache, tiredness and weakness. Tell your doctor promptly about any troublesome side effect, and seek urgent help for swelling or breathing difficulty. Tell your doctor or pharmacist if you notice any side effect, especially swelling or breathing trouble.
Safety and precautions
Do not take Nuvace if you are allergic to Ramipril or other ACE inhibitors, if you have had angioedema, or in certain kidney and circulation conditions; your doctor will check this. Pregnancy must be ruled out before starting treatment, and if you become pregnant while taking it, contact your doctor right away so the treatment can be changed. Do not take this medicine with sacubitril/valsartan or aliskiren-containing products. Keep out of reach of children.
Frequently asked questions
Why is Nuvace prescribed?
Nuvace is prescribed for three main situations: high blood pressure, where it may be used alone or with other antihypertensive medicines; congestive heart failure, sometimes together with diuretics; and for patients who, in the first days after an acute heart attack, show clinical signs of congestive heart failure. It is not a medicine for sudden illness and should be taken only under a doctor's care.
How should I take Nuvace?
Regular follow-up is important to monitor your progress. Swallow the tablet with water.
Can Nuvace cause side effects?
Less common side effects are low blood pressure with symptoms like lightheadedness, cough, nausea, vomiting, diarrhoea, rash, and hives. Nuvace 5 mg is generally well tolerated, but some people notice dizziness, headache, tiredness or weakness.
Can I use Nuvace in pregnancy or while breastfeeding?
Do not take Nuvace if you are allergic to Ramipril or other ACE inhibitors, if you have had angioedema, or in certain kidney and circulation conditions; your doctor will check this. Pregnancy must be ruled out before starting treatment, and if you become pregnant while taking it, contact your doctor right away so the treatment can be changed.
Hypertension; to lower blood pressure, as single-drug therapy or in combination with other antihypertensive agents.
Congestive heart failure; also in combination with diuretics.
Treatment of patients who- within the first few days after an acute myocardial infarction- have demonstrated clinical signs of congestive heart failure.
... Read more
Ramipril indicated in the following cases:
Hypertension; to lower blood pressure, as single-drug therapy or in combination with other antihypertensive agents.
Congestive heart failure; also in combination with diuretics.
Treatment of patients who- within the first few days after an acute myocardial infarction- have demonstrated clinical signs of congestive heart failure.
Treatment of non-diabetic or diabetic overt glomerular or incipient nephropathy.
Reduction in the risk of myocardial infarction, stroke, or cardiovascular death in patients with an increased cardiovascular risk, such as manifest coronary heart disease (with or without a history of myocardial infarction), a history of stroke, a history of peripheral vascular disease, or diabetes mellitus that is accompanied by at least one other cardiovascular risk factor (microalbuminuria, hypertension, elevated total cholesterol levels, low high-density lipoprotein cholesterol levels, smoking).
Pharmacology
Ramipril is an angiotensin converting enzyme (ACE) inhibitor, which after hydrolysis to ramiprilat, blocks the conversion of angiotensin I to the vasoconstrictor substance, angiotensin II. So, inhibition of ACE by ramipril results in decreased plasma angiotensin II, which leads to decreased vasopressor activity and decreased aldosterone secretion. Thus ramipril exerts its antihypertensive activity. It is also effective in the management of heart failure and reduction of the risk of stroke, myocardial infarction and death from cardiovascular events. It is long acting and well tolerated; so, can be used in long term therapy.
Dosage & Administration
Dosage of Ramipril must be adjusted according to the patient tolerance and response.
Hypertension: For the management of hypertension in adults not receiving a diuretic, the usual initial dose of Ramipril is 1.25-2.5 mg once daily. Dosage generally is adjusted no more rapidly than at 2 week intervals. The usual maintenance dosage in adults is 2.5-20 mg daily given as a single dose or in 2 divided doses daily. If BP is not controlled with Ramipril alone, a diuretic may be added.
Congestive heart failure after myocardial infarction: In this case, Ramipril therapy may be initiated as early as 2 days after myocardial infarction. An initial dose of 2.5 mg twice daily is recommended, but if hypotension occurs, dose should be reduced to 1.25 mg twice daily. Therapy is then titrated to a target daily dose of 5 mg twice daily.
Prevention of major cardiovascular events: In this case, the recommended dose is 2.5 mg once daily for the first week of therapy and 5 mg once daily for the following 3 weeks; dosage then may be increased, as tolerated, to a maintenance dosage of 10 mg once daily.
Dosage in renal impairment:
For patients with hypertension and renal impairment: The recommended initial dose is 1.25 mg Ramipril once daily. Subsequent dosage should be titrated according to individual tolerance and BP response, up to a maximum of 5 mg daily.
For patients with heart failure and renal impairment: The recommended dose is 1.25 mg once daily. The dose may be increased to 1.25 mg twice daily and up to a maximum dose of 2.5 mg twice daily depending upon clinical response and tolerability.
Interaction
Concomitant administration with diuretics may lead to serious hypotension and in addition dangerous hyperkalemia with potassium sparing diuretics. Concomitant therapy with lithium may increase the serum lithium concentration. Reduction in BP may affect the ability to drive and operate machinery and this may be exacerbated by alcohol. NSAIDs may reduce the antihypertensive effect of Ramipril and cause deterioration of renal function.
Contraindications
Ramipril must not be used
in patients with hypersensitivity to ramipril, to any other ACE inhibitor, or any of the excipients of Ramipril.
in patients with a history of angioedema.
concomitantly with sacubitril/valsartan therapy. Do not initiate Ramipril until sacubitril/valsartan is eliminated from the body. In case of switch from Ramipril to sacubitril/valsartan, do not start sacubitril/valsartan until Ramipril is eliminated from the body.
in patients with haemodynamically relevant renal artery stenosis, bilateral or unilateral in the single kidney.
in patients with hypotensive or haemodynamically unstable states.
with aliskiren-containing medicines in patients with diabetes or with moderate to severe renal impairment (creatinine clearance <60 ml/min).
with angiotensin II receptor antagonists (AIIRAs) in patients with diabetic nephropathy.
during pregnancy.
Concomitant use of ACE inhibitors and extracorporeal treatments leading to contact of blood with negatively charged surfaces must be avoided, since such use may lead to severe anaphylactoid reactions. Such extracorporeal treatments include dialysis or haemofiltration with certain high-fux (e.g. polyacrylonitril) membranes and low-density lipoprotein apheresis with dextran sulfate.
Side Effects
Ramipril is generally well tolerated. Dizziness, headache, fatigue and asthenia are commonly reported side effects. Other side effects occurring less frequently include symptomatic hypotension, cough, nausea, vomiting, diarrhoea, rash, urticaria, oliguria, anxiety, amnesia etc. Angioneurotic oedema, anaphylactic reactions and hyperkalaemia have also been reported rarely.
Pregnancy & Lactation
Ramipril must not be taken during pregnancy. Therefore, pregnancy must be excluded before starting treatment. Pregnancy must be avoided in cases where treatment with ACE inhibitors is indispensable. If the patient intends to become pregnant, treatment with ACE inhibitors must be discontinued, i.e. replaced by another form of treatment. If the patient becomes pregnant during treatment, medication with Ramipril must be replaced as soon as possible by a treatment regimen without ACE inhibitors. Otherwise, there is a risk of harm to the fetus. Ramipril is not recommended during breastfeeding.
Precautions & Warnings
Ramipril should be used with caution in patients with impaired renal function, hyperkalaemia, hypotension, and impaired hepatic function.
Overdose Effects
Sign and symptom: Overdosage may cause excessive peripheral vasodilatation (with marked hypotension, shock), bradycardia, electrolyte disturbances, and renal failure.
Management: Primary detoxifcation by, for example, gastric lavage, administration of adsorbents, sodium sulfate; (if possible during the frst 30 minutes). In the event of hypotension administration of α1-adrenergic agonists (e.g. norepinephrine, dopamine) or angiotensin II (angiotensinamide), which is usually available only in scattered research laboratories, must be considered in addition to volume and salt substitution.
Storage Conditions
Store at 30° or below, protect from light. Keep out of the reach of children. Do not use later than the date of expiry. To be dispensed only on the prescription of a registered physician.
Alternative brands of Ramipril
Other brands with the same generic name, cheapest first.